Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report22 November 2023
Urenco will turn out in force for the biggest event in the industry calendar next week, the World Nuclear Exhibition in Paris (WNE).
Under the banner of “One Urenco”, teams from across the company will be on hand to engage and speak to delegates at its stand area at D035 in Hall 7; including Commercial, Stable and Medical Isotopes, Urenco Nuclear Stewardship, and the Young Persons Network.
The exhibition runs from Tuesday, November 28 to Thursday, November 30 at the Parc des Expositions, and Urenco is also one of the sponsors of the UK Pavilion.
We will be hosting a workshop on November 28 from 4.30pm entitled “Enriching the future for a sustainable net zero world.”
Urenco’s People and Culture Transformation Programme Director Marielle Smit will be taking part in a panel discussion on November 30 on the topic of “Building a diverse pool of talents for nuclear industry success”.
During the course of the exhibition we will be setting out and discussing how as a company we are:
• Bolstering worldwide energy security through our capacity programme
• Turning ambition into action for a net zero world
• Supporting the next generation of reactors with advanced fuels and …
• Nurturing the next generation of scientists and engineers
Find out more about the exhibition here.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries